A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects
NCT07301333 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2026-04-07
Summary
This is a phase I, randomised, single-blind placebo-controlled, 2-part study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of single and multiple oral doses of HRS-6257 in healthy volunteers.
Conditions
Interventions
- DRUG
-
HRS-6257
HRS-6257
- DRUG
-
placebo
Sponsors & Collaborators
-
Shanghai Hengrui Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-12-30
- Primary Completion
- 2026-05-31
- Completion
- 2026-05-31
Countries
- China
Study Locations
More Related Trials
-
A Study of Whether 2 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication
NCT02089581 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study in Healthy Subjects Which Aims to Investigate the Safety, the Tolerability and the Effects of GRT0151Y and How the Compound is Taken up and Excreted From the Body
NCT03761407 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Oral Morphine Versus Nasal Ketamine Spray With Chitosan in Cancer Pain Outpatients
NCT02591017 ·Status: TERMINATED ·Phase: PHASE3
-
True Functional Restoration and Analgesia in Non-Radicular Low Back Pain
NCT01455519 ·Status: COMPLETED ·Phase: PHASE4
-
A Single Dose Study of SHR0410 in Healthy Male Participants
NCT03493191 ·Status: COMPLETED ·Phase: PHASE1
-
Investigating Composite Biomarkers for Pain Catastrophizing
NCT04787198 ·Status: RECRUITING ·Phase: NA
-
Pharmacokinetic Study of Single and Multiple Intravenous Administration of Nalbuphine Hydrochloride Injection in Healthy Chinese Volunteers
NCT06902103 ·Status: COMPLETED ·Phase: PHASE1
-
An Efficacy and Safety Study of Acetaminophen Plus Tramadol Hydrochloride (JNS013) in Participants With Chronic Pain
NCT00736853 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain
NCT00365898 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine (Second Sub-Project)
NCT04700007 ·Status: COMPLETED ·Phase: NA
-
Brain Response to Pain Control in People With Chronic Pain
NCT01878019 ·Status: COMPLETED
-
A Study of Whether 3 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication
NCT02446561 ·Status: COMPLETED ·Phase: PHASE1
-
A Long-term Efficacy and Safety Study of Tramadol Hydrochloride Plus Acetaminophen (JNS013) in Japanese Participants With Chronic Pain
NCT00736957 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 1 Study of CG001419 Administered Orally in Healthy Subjects
NCT06636500 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure to Investigate the Safety and Tolerability of GRT0151Y and to Find Out Which Single Dose of the Compound is Maximally Tolerated
NCT03765658 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess How the Body Processes a Strong Painkiller When it is Given Alongside a Drug That Counteracts the Side Effects of Strong Painkillers in a Fasted and Fed State.
NCT02133820 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects
NCT02083315 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients
NCT01621100 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration
NCT01709721 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy
NCT07188857 ·Status: NOT_YET_RECRUITING
-
Cannabidiol, Morphine, Pain
NCT04030442 ·Status: RECRUITING ·Phase: PHASE1
-
Morphine Modulation of The Brain's Pain Matrix
NCT01245244 ·Status: COMPLETED ·Phase: PHASE4
-
Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain
NCT00485225 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Improvement of Pain and Health-Related Quality of Life in Patients With Chronic Non-Malignant Pain Taking Tramadol Hydrochloride and Acetaminophen
NCT01819805 ·Status: COMPLETED
-
Safety & Efficacy of Nuberol Forte® in Pain Management
NCT04765787 ·Status: COMPLETED